Advisors Asset Management Inc. decreased its position in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) by 35.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 18,881 shares of the scientific and technical instruments company's stock after selling 10,203 shares during the quarter. Advisors Asset Management Inc.'s holdings in Itron were worth $1,978,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of ITRI. Captrust Financial Advisors boosted its holdings in shares of Itron by 6.3% during the 4th quarter. Captrust Financial Advisors now owns 2,144 shares of the scientific and technical instruments company's stock valued at $233,000 after acquiring an additional 128 shares in the last quarter. CoreCap Advisors LLC lifted its holdings in Itron by 25.5% during the 4th quarter. CoreCap Advisors LLC now owns 616 shares of the scientific and technical instruments company's stock worth $67,000 after buying an additional 125 shares during the period. Deutsche Bank AG lifted its holdings in Itron by 6.4% during the 4th quarter. Deutsche Bank AG now owns 260,360 shares of the scientific and technical instruments company's stock worth $28,270,000 after buying an additional 15,717 shares during the period. Ethic Inc. lifted its holdings in Itron by 21.2% during the 4th quarter. Ethic Inc. now owns 3,846 shares of the scientific and technical instruments company's stock worth $418,000 after buying an additional 673 shares during the period. Finally, Janus Henderson Group PLC lifted its holdings in Itron by 2.4% during the 4th quarter. Janus Henderson Group PLC now owns 536,288 shares of the scientific and technical instruments company's stock worth $58,233,000 after buying an additional 12,810 shares during the period. Institutional investors and hedge funds own 96.19% of the company's stock.
Itron Trading Down 0.8%
Shares of NASDAQ:ITRI traded down $0.97 during midday trading on Friday, reaching $119.54. The company's stock had a trading volume of 134,603 shares, compared to its average volume of 593,526. The firm has a 50 day moving average price of $128.21 and a two-hundred day moving average price of $117.28. Itron, Inc. has a fifty-two week low of $90.11 and a fifty-two week high of $140.04. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.75 and a current ratio of 2.04. The firm has a market capitalization of $5.47 billion, a price-to-earnings ratio of 20.45, a PEG ratio of 0.65 and a beta of 1.46.
Itron (NASDAQ:ITRI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.29. The business had revenue of $606.76 million for the quarter, compared to analyst estimates of $610.36 million. Itron had a return on equity of 19.69% and a net margin of 11.05%.The company's quarterly revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.21 earnings per share. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. As a group, analysts forecast that Itron, Inc. will post 5.33 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several brokerages have commented on ITRI. Wall Street Zen raised Itron from a "hold" rating to a "buy" rating in a report on Saturday, August 2nd. JPMorgan Chase & Co. raised Itron from a "neutral" rating to an "overweight" rating and lifted their target price for the stock from $128.00 to $145.00 in a report on Thursday, July 31st. Roth Capital lifted their target price on Itron from $130.00 to $150.00 and gave the stock a "buy" rating in a report on Tuesday, July 22nd. TD Cowen boosted their price objective on Itron from $139.00 to $145.00 and gave the company a "buy" rating in a research note on Friday, June 20th. Finally, Stephens set a $130.00 price objective on Itron in a research note on Monday, August 4th. Ten research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, Itron currently has a consensus rating of "Moderate Buy" and an average target price of $136.55.
Get Our Latest Research Report on ITRI
Insiders Place Their Bets
In other Itron news, SVP Justin K. Patrick sold 388 shares of the stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $48,620.28. Following the transaction, the senior vice president owned 20,761 shares in the company, valued at approximately $2,601,560.91. This represents a 1.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Donald L. Reeves III sold 547 shares of the stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $68,544.57. Following the completion of the transaction, the senior vice president owned 19,604 shares in the company, valued at approximately $2,456,577.24. The trade was a 2.71% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 3,037 shares of company stock valued at $380,566. 1.45% of the stock is currently owned by corporate insiders.
About Itron
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Featured Articles

Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.